Two commercial assay kits for detecting antibody to hepatitis A virus
(anti-HAV) have been modified in order to increase their sensitivity.
These modifications are made by less dilution of the test serum, in th
e case of Abbott HAVAB-M assay, or by an increase in the volumetric ra
tio of the test serum to the labeled anti-HAV in the case of the Abbot
t HAVAB assay. These modifications result in 5- to 20-fold increases i
n test sensitivity and enable the detection of anti-HAV at 2-3 weeks f
ollowing vaccination. The earlier detection of anti-HAV is important t
o vaccine development in assuring the presence of antibody levels in t
ravelers sooner after vaccination. (C) 1993 Wiley-Liss, Inc.